Marshall Wace, LLP Rhythm Pharmaceuticals, Inc. Transaction History

Marshall Wace, LLP

$72.2 Billion
Q2 2024

A detailed history of Marshall Wace, LLP transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 106,809 shares of RYTM stock, worth $5.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

106,809

Previous 19,750 440.81%

Holding current value

$5.3 Million

Previous $855,000 412.87%

% of portfolio

0.01%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$35.41 - $44.37 $3.08 Million - $3.86 Million	87,059 Added 440.81%	106,809 $4.39 Million
Q1 2024 May 15, 2024	BUY	$39.12 - $52.44 $772,620 - $1.04 Million	19,750 New	19,750 $855,000
Q3 2023 Nov 14, 2023	SELL	$15.81 - $27.8 $29,675 - $52,180	-1,877 Reduced 5.16%	34,494 $790,000
Q2 2023 Aug 14, 2023	SELL	$16.32 - $21.15 $937,992 - $1.22 Million	-57,475 Reduced 61.24%	36,371 $599,000
Q1 2023 May 15, 2023	BUY	$16.88 - $34.24 $1.22 Million - $2.48 Million	72,563 Added 340.94%	93,846 $1.67 Million
Q4 2022 Feb 14, 2023	BUY	$22.21 - $30.25 $472,695 - $643,810	21,283 New	21,283 $619,000
Q2 2021 Aug 13, 2021	SELL	$18.52 - $22.55 $3.31 Million - $4.03 Million	-178,757 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$20.25 - $39.49 $3.23 Million - $6.3 Million	159,599 Added 833.07%	178,757 $3.8 Million
Q4 2020 Feb 16, 2021	SELL	$21.17 - $32.61 $191,249 - $294,598	-9,034 Reduced 32.04%	19,158 $570,000
Q3 2020 Nov 16, 2020	BUY	$18.13 - $30.61 $325,161 - $548,990	17,935 Added 174.86%	28,192 $611,000
Q2 2020 Aug 13, 2020	BUY	$14.41 - $25.35 $147,803 - $260,014	10,257 New	10,257 $229,000
Q4 2019 Feb 14, 2020	SELL	$19.53 - $25.5 $44,879 - $58,599	-2,298 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$18.62 - $24.51 $42,788 - $56,323	2,298 New	2,298 $50,000
Q2 2019 Aug 14, 2019	SELL	$21.11 - $28.48 $310,633 - $419,083	-14,715 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$24.76 - $31.66 $307,444 - $393,122	12,417 Added 540.34%	14,715 $403,000
Q4 2018 Feb 14, 2019	BUY	$24.11 - $31.34 $55,404 - $72,019	2,298 New	2,298 $62,000

Others Institutions Holding RYTM

# of Institutions

178

Shares Held

69.1M

Call Options Held

467K

Put Options Held

224K

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $2.77B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Rhythm Pharmaceuticals, Inc. Transaction History